The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's...
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease
About this item
Full title
Author / Creator
Publisher
BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
It is suggested that neuroinflammation, in which activated microglial cells play a relevant role, contributes to the development of Parkinson's disease (PD). Consequently, the modulation of microglial activation is a potential therapeutic target to be taken into account to act against the dopaminergic neurodegeneration occurring in this neurologica...
Alternative Titles
Full title
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A661396029
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A661396029
Other Identifiers
ISSN
1742-2094
E-ISSN
1742-2094
DOI
10.1186/s12974-021-02132-z
